Back to Journals » Therapeutics and Clinical Risk Management » Volume 11

Perspectives

Integrating risk minimization planning throughout the clinical development and commercialization lifecycle: an opinion on how drug development could be improved

         
Total article views   Abstract views HTML views PDF downloads Totals
15,111 Dovepress* 12,057 1,436+ 2,178 13,493
PubMed Central* 0 1,618 426 1,618
Totals 12,057 3,054 2,604 15,111
*Since 26 February 2015
+Since July 2016

View citations on PubMed Central and Google Scholar